-
公开(公告)号:EA004859B1
公开(公告)日:2004-08-26
申请号:EA200200048
申请日:2002-01-17
Applicant: SERVIER LAB
Inventor: CASARA PATRICK , LE DIGUARHER THIERRY , DOREY GILBERT , HICKMAN JOHN , PIERRE ALAIN , TUCKER GORDON , GUILBAUD NICOLAS
IPC: C07C317/00 , A61K31/4164 , A61K31/417 , A61K31/4178 , A61K31/4406 , A61K31/4409 , A61K31/454 , A61P9/00 , A61P9/10 , A61P25/00 , A61P35/00 , C07D213/36 , C07D213/38 , C07D213/57 , C07D233/54 , C07D233/58 , C07D233/61 , C07D233/64 , C07D401/06 , C07D211/82 , A61K31/4174
Abstract: Соединенияформулы (I)где X представляетсобойсвязьилиалкиленовую, СО, S(O), -S(O)-A-, -СО-А, -А-S(O)-A'- или -A-CO-A'-группу, Y представляетсобойарильную, гетероарильную, циклоалкильнуюилигетероциклоалкильнуюгруппу, каждаяизкоторыхнезамещенаилизамещена, R, R, Rи R, каждаянезависимоотдругих, представляютсобойатомводородаилиарильную, гетероарильную, циклоалкильнуюилигетероциклоалкильнуюгруппу, каждаяизкоторыхнезамещенаилизамещена, или R, R, Rи R, взятыепопарно, вместеобразуютсвязьилиобразуютслитоебензольноекольцо, илислитыйароматический, иличастичноненасыщенныйгетероцикл, Тпредставляетсобойгруппу -CH(R)-, -N(R)- или -N(R)CO-, V представляетсобойатомводородаилинезамещеннуюилизамещеннуюарильнуюилигетероарильнуюгруппу, Апредставляетсобойгруппу [C(R)(R')], Rи Rимеютзначения, указанныев описании. Фармацевтическиекомпозиции.
-
公开(公告)号:AU2003201326A1
公开(公告)日:2003-10-02
申请号:AU2003201326
申请日:2003-03-18
Applicant: SERVIER LAB
Inventor: KRAUS-BERTHIER LAURENCE , TUCKER GORDON , PIERRE ALAIN , HICKMAN JOHN , KUCHARCZYK NATHALIE , FAUCHERE JEAN-LUC , TIZOT ANDRE , DHAINAUT ALAIN , GOLDSTEIN SOLO
IPC: C07D401/06 , A61K31/517 , A61P9/00 , A61P25/00 , A61P35/00 , C07D401/14 , C07D403/06 , C07D407/14 , C07D409/14 , C07D521/00
Abstract: Quinazoline derivatives (I) are new. Quinazoline derivatives of formula (I), their enantiomers, diastereomers and salts are new. A = bond, 1-6C alkylene, 2-6C alkenylene, 2-6C alkynylene, T, A1-T, T-A1, A1-T-A1, or A1-T-A'1-T'; T, T' = carbonyl, carbonyloxy, thio, sulfirylsulfonyl, oxy, amino, 1-6C aminoalkyl, aminoaryl, carbonylamino, carbonylamino-1-6C alkyl, carbonylaminoaryl, oxycarbonyl, aminocarbonyl, 1-6C aminoalkylcarbonyl, aminoarylcarbonyl, sulfonylamino, sulfonylamino-1-6C alkyl, sulfonylaminoaryl, aminosulfonyl, amino-1-6C alkylsulfonyl or aminoarylsulfonyl; A1, A'1 = 1-6C alkylene, 2-6C alkenylene or 2-6C alkynylene; B = 1-6C alkyl, aryl, 3-10C cycloalkyl, Het1, Het2, arylaminoaryl or aryl-1-6C alkylaryl (all optionally substituted by 1-3 Z); D = 1-6C alkylene (where 1 C atom may be substituted by B); X = O or S; Z, R1 = halo, 1-6C alkyl, 1-6C alkoxy, OH, SH, CN, NO2, NH2, 1-6C alkylamino, di-1-6C alkylamino, 1-4C perhaloalkyl, carboxy, 1-6C alkoxycarbonyl, aminocarbonyl, 1-6C alkylaminocarbonyl, di-1-6C alkylaminocarbonyl, carbamoyl or 1-6C alkoxycarbonylamino; R2 = H, or 1-6C alkyl, aryl, 3-10C cycloalkyl, Het1, Het2, aryl-1-6C alkyl or Het2-1-6C alkyl-3-10C cycloalkyl-1-6C alkyl or Het1-1-6C alkyl (all optionally substituted by halo, 1-6C alkyl, 1-6C alkoxy, OH, SH, CN, NO2, NH2, 1-6C alkylamino, di-1-6C alkylamino, 1-4C perhaloalkyl, carboxy, 1-6C alkoxycarbonyl, aminocarbonyl, 1-6C alkylaminocarbonyl, di-1-6C alkylaminocarbonyl, carbamoyl, 1-6C alkoxycarbonylamino, or aryl-1-6C alkyl or arylamino (both optionally substituted by 1-3 Z)); aryl = phenyl, naphthyl or biphenyl; Het1 = 5-7 membered saturated or partially unsaturated mono- or polycyclic heterocycloalkyl containing 1-3 N, O or S atoms; Het2 = 5-11 membered mono- or bicyclic aromatic ring containing 1-3 N, O or S; m = 0-4; and n = 0-3; provided that when the 2 N atoms of the imidazol ring are substituted, the imidazole moiety becomes a cationic imidazolium moiety. An Independent claim is also included for the preparation of (I).
-
公开(公告)号:PL359208A1
公开(公告)日:2003-09-22
申请号:PL35920803
申请日:2003-03-17
Applicant: SERVIER LAB
Inventor: GOLDSTEIN SOLO , DHAINAUT ALAIN , TIZOT ANDRE , FAUCHERE JEAN-LUC , KUCHARCZYK NATHALIE , HICKMAN JOHN , PIERRE ALAIN , TUCKER GORDON , KRAUS-BERTHIER LAURENCE
IPC: C07D401/06 , A61K31/517 , A61P9/00 , A61P25/00 , A61P35/00 , C07D401/14 , C07D403/06 , C07D407/14 , C07D409/14 , C07D521/00
Abstract: Quinazoline derivatives (I) are new. Quinazoline derivatives of formula (I), their enantiomers, diastereomers and salts are new. A = bond, 1-6C alkylene, 2-6C alkenylene, 2-6C alkynylene, T, A1-T, T-A1, A1-T-A1, or A1-T-A'1-T'; T, T' = carbonyl, carbonyloxy, thio, sulfirylsulfonyl, oxy, amino, 1-6C aminoalkyl, aminoaryl, carbonylamino, carbonylamino-1-6C alkyl, carbonylaminoaryl, oxycarbonyl, aminocarbonyl, 1-6C aminoalkylcarbonyl, aminoarylcarbonyl, sulfonylamino, sulfonylamino-1-6C alkyl, sulfonylaminoaryl, aminosulfonyl, amino-1-6C alkylsulfonyl or aminoarylsulfonyl; A1, A'1 = 1-6C alkylene, 2-6C alkenylene or 2-6C alkynylene; B = 1-6C alkyl, aryl, 3-10C cycloalkyl, Het1, Het2, arylaminoaryl or aryl-1-6C alkylaryl (all optionally substituted by 1-3 Z); D = 1-6C alkylene (where 1 C atom may be substituted by B); X = O or S; Z, R1 = halo, 1-6C alkyl, 1-6C alkoxy, OH, SH, CN, NO2, NH2, 1-6C alkylamino, di-1-6C alkylamino, 1-4C perhaloalkyl, carboxy, 1-6C alkoxycarbonyl, aminocarbonyl, 1-6C alkylaminocarbonyl, di-1-6C alkylaminocarbonyl, carbamoyl or 1-6C alkoxycarbonylamino; R2 = H, or 1-6C alkyl, aryl, 3-10C cycloalkyl, Het1, Het2, aryl-1-6C alkyl or Het2-1-6C alkyl-3-10C cycloalkyl-1-6C alkyl or Het1-1-6C alkyl (all optionally substituted by halo, 1-6C alkyl, 1-6C alkoxy, OH, SH, CN, NO2, NH2, 1-6C alkylamino, di-1-6C alkylamino, 1-4C perhaloalkyl, carboxy, 1-6C alkoxycarbonyl, aminocarbonyl, 1-6C alkylaminocarbonyl, di-1-6C alkylaminocarbonyl, carbamoyl, 1-6C alkoxycarbonylamino, or aryl-1-6C alkyl or arylamino (both optionally substituted by 1-3 Z)); aryl = phenyl, naphthyl or biphenyl; Het1 = 5-7 membered saturated or partially unsaturated mono- or polycyclic heterocycloalkyl containing 1-3 N, O or S atoms; Het2 = 5-11 membered mono- or bicyclic aromatic ring containing 1-3 N, O or S; m = 0-4; and n = 0-3; provided that when the 2 N atoms of the imidazol ring are substituted, the imidazole moiety becomes a cationic imidazolium moiety. An Independent claim is also included for the preparation of (I).
-
公开(公告)号:PT979816E
公开(公告)日:2003-08-29
申请号:PT99402016
申请日:1999-08-09
Applicant: SERVIER LAB
Inventor: HANESSIAN STEPHEN , CAIGNARD DANIEL-HENRI , TUCKER GORDON , ATASSI GHANEM , RENARD PIERRE
IPC: A61K31/18 , A61K31/185 , C12N9/99 , A61K31/35 , A61K31/351 , A61K31/4406 , A61K31/4418 , A61K31/445 , A61P43/00 , C07C319/14 , C07C319/20 , C07C323/60 , C07D211/20 , C07D213/34 , C07D309/04
Abstract: Hydroxamic acid derivatives (I) are new. Hydroxamic acid derivatives of formula (I) and their acid and base addition salts are new. R1 = 1-6C alkyl (optionally substituted by at least one OH, halo, 1-6C alkoxy, mercapto, 1-6C alkylthio, aryl, 1-6C acyl or amino (optionally substituted by one or two 1-6C alkyl, cycloalkyl or aryl)), 1-6C acyl, cycloalkyl, aryl, heterocyclic group or aminocarbonyl-1-6C alkyl (with amino optionally substituted by one 1-6C alkyl (optionally substituted by at least one aryl, 1-6C arylalkyl, cycloalkyl or 1-6C alkylaminocarbonyl; R2 = 1-4C alkylene; R3 = X or T-U'-V'- X = 1-6C alkyl, 1-6C acyl, 1-6C alkoxycarbonyl, 1-6C aminoalkyl (amino optionally substituted by one or two 1-6C alkyl), 1-6C hydroxyalkyl, 1-6C carboxyalkyl, 1-6C aminocarbonylalkyl, 1-6C mercaptoalkyl, cycloalkyl, aryl or heterocyclic; T = aryl or heterocyclic; U' = single bond, S, O, NH, carbonyl, -R8O-, -R8S-, -R8NH-, -R8OR9-, -R8-NH-R9-, -R8-CO-R9- or -R9- (with R8 bound to T and R9 bound to V'); R8 = 1-6C alkylene; R9 = arylene or heteroarylene; V' = 1-6C alkylene; R4 = biaryl, arylheteroaryl, heteroarylaryl, 1-6C alkyl (optionally substituted by one heterocyclic group), cycloalkyl, aryl, 1-6C arylalkyl, cycloalkyl-1-6C alkyl or heterocyclic; and provided that R4 is 1-6C alkyl (optionally substituted by one heterocyclic group), cycloalkyl, aryl, 1-6C arylalkyl, cycloalkyl-1-6C alkyl or heterocyclic, when R3 is T-U'-V'-. An Independent claim is also included for the preparation of (I).
-
公开(公告)号:NZ524771A
公开(公告)日:2003-08-29
申请号:NZ52477103
申请日:2003-03-17
Applicant: SERVIER LAB
Inventor: GOLDSTEIN SOLO , DHAINAUT ALAIN , TIZOT ANDRE , FAUCHERE JEAN-LUC , KUCHARCZYK NATHALIE , HICKMAN JOHN , PIERRE ALAIN , TUCKER GORDON , KRAUS-BERTHIER LAURENCE
IPC: C07D401/06 , A61K31/517 , A61P9/00 , A61P25/00 , A61P35/00 , C07D401/14 , C07D403/06 , C07D407/14 , C07D409/14 , C07D521/00
Abstract: A compound of formula (I) wherein; A represents a bond, alkylene, alkenylene, alkynylene, T, *-A1-T-, *-T-A1, *-A1-T-A'1- or *-A1-T-A'1-T'- group, where T, T', A1 and A'1 are described in the specification; B represents optionally substituted alkyl, aryl, heteroaryl, cycloalkyl, heterocycloalkyl, arylaminoaryl or arylalkylaryl; D represents an optionally substituted alkylene group; X is O or S; R1 is halogen, alkyl, alkoxy, hydroxy, mercapto, cyano, amino, alkylamino, dialkylamino, nitro, perhaloalkyl, carboxy, alkoxycarbonyl, aminocarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, carbamoyl or an alkoxycarbonylamino group; R2 is H or optionally substituted alkyl, aryl, heteroaryl, cycloalkyl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl or a heterocycloalkylalkyl group. M is 0-4 inclusive; and n is 0-3 inclusive.
-
公开(公告)号:AR029485A1
公开(公告)日:2003-07-02
申请号:ARP010101058
申请日:2001-03-07
Applicant: SERVIER LAB
Inventor: CASARA PATRICK , PERRON-SIERRA FRANCOISE , ATASSI GHANEM , TUCKER GORDON , SAINT-DIZIER DOMINIQUE
IPC: C07D233/24 , A61K31/4164 , A61K31/4168 , A61K31/417 , A61K31/4184 , A61K31/426 , A61K31/4375 , A61K31/44 , A61K31/4402 , A61K31/505 , A61K31/55 , A61P9/00 , A61P19/10 , A61P27/02 , A61P29/00 , A61P33/14 , A61P35/00 , A61P43/00 , C07D213/36 , C07D213/74 , C07D223/04 , C07D223/12 , C07D233/48 , C07D233/54 , C07D235/10 , C07D235/14 , C07D235/30 , C07D239/14 , C07D277/18 , C07D277/20 , C07D277/42 , C07D401/12 , C07D403/12 , C07D471/04 , A61K31/402
Abstract: Compuestos de formula (1) en la cual: G representa un grupo fenilo o un grupo heterocíclico aromático o parcialmente insaturado, de 6 eslabones, que contiene de 1 a 2 heteroátomos elegidos entre nitrogeno y oxígeno, no substituido o substituido por R1, R2, R3 y/o R4; G1 y G2 representan independientemente, un átomo de carbono o de nitrogeno; -T1- representa un grupo elegido entre -CH2-CH2-, -CH=CH-, =CH-CH2-, y en ese caso, -T2- representa un enlace, o bien -T1- representa un grupo elegido entre -CH2- y -CH- y en ese caso -T2- representa un grupo -CH2-, =CH-, (a) o (b); R1, R2, R3 y R4, representan independientemente, un átomo de halogeno, un grupo alquilo, perhalogenoalquilo, ciano, nitro, OR7, NR6R6', COOR6, CONR6R6', COR6, S(O)nR6, siendo n igual a 0, 1 o 2; R5 representa un grupo -(CH2)m-COOR6; R6 y R6' representan independientemente, un átomo de hidrogeno, un grupo alquilo, arilo eventualmente substituido o arilalquilo eventualmente substituido; R7 representa un átomo de hidrogeno o un grupo alquilo; -W- representa un grupo -CH-, =C-, o -C= y -A- representa un grupo -CO-, -CH2-, =CH- o -CH=, o bien -W- representa un átomo de nitrogeno y -A- representa un grupo -CO- o -CH2-; -X- representa un grupo elegido entre -CO-X1-, -CO-NR6-X1-, -NR6-CO-X1-, -O-X1-, -SO2-NR6-X1-, y -S(O)n-X1-, en los cuales n está comprendido inclusivamente entre 0 y 2, y X1 representa un grupo alquileno; -Y- representa un grupo elegido entre -Y1-, -Y2-Y1- y -Y1-Y2-Y1-, en los cuales Y1 representa un grupo alquileno, alquenileno o alquinileno, e Y2 representa un grupo arileno, heteroarileno, cicloalquileno o heterocicloalquileno; Z- representa un grupo elegido entre Z1-, Z10-NR6-, y Z10-NR6-CO- en los cuales Z10 representa un grupo alquilo o Z1, y Z1 representa un grupo elegido entre Z2-, Z20-NR6-, Z20-NR6-CO-, o (c), en los cuales Z20 representa un grupo alquilo, heteroalquilo o Z2, y Z2 representa un grupo heteroarilo eventualmente substituido, heterocicloalquilo eventualmente substituido, heteroarilalquilo eventualmente substituido, heterocicloalquilalquilo eventualmente substituido, arilheteroarilo fusionado eventualmente substituido, arilheterocicloalquilo fusionado eventualmente substituido, heterocicloalquilheteroarilo fusionado eventualmente substituido, heteroarilheteroarilo fusionado eventualmente substituido, o cicloalquilheterocicloalquilo fusionado; y m es un entero comprendido en forma incluida entre 1 y 6. Estos compuestos son utiles en la preparacion de medicamentos.
-
公开(公告)号:DE69907337D1
公开(公告)日:2003-06-05
申请号:DE69907337
申请日:1999-08-09
Applicant: SERVIER LAB
Inventor: HANESSIAN STEPHEN , ATASSI GHANEM , TUCKER GORDON , CAIGNARD DANIEL-HENRI , RENARD PIERRE
IPC: C12N9/99 , A61K31/18 , A61K31/185 , A61K31/35 , A61K31/351 , A61K31/4406 , A61K31/4418 , A61K31/445 , A61P43/00 , C07C319/14 , C07C319/20 , C07C323/60 , C07D211/20 , C07D213/34 , C07D309/04
Abstract: Hydroxamic acid derivatives (I) are new. Hydroxamic acid derivatives of formula (I) and their acid and base addition salts are new. R1 = 1-6C alkyl (optionally substituted by at least one OH, halo, 1-6C alkoxy, mercapto, 1-6C alkylthio, aryl, 1-6C acyl or amino (optionally substituted by one or two 1-6C alkyl, cycloalkyl or aryl)), 1-6C acyl, cycloalkyl, aryl, heterocyclic group or aminocarbonyl-1-6C alkyl (with amino optionally substituted by one 1-6C alkyl (optionally substituted by at least one aryl, 1-6C arylalkyl, cycloalkyl or 1-6C alkylaminocarbonyl; R2 = 1-4C alkylene; R3 = X or T-U'-V'- X = 1-6C alkyl, 1-6C acyl, 1-6C alkoxycarbonyl, 1-6C aminoalkyl (amino optionally substituted by one or two 1-6C alkyl), 1-6C hydroxyalkyl, 1-6C carboxyalkyl, 1-6C aminocarbonylalkyl, 1-6C mercaptoalkyl, cycloalkyl, aryl or heterocyclic; T = aryl or heterocyclic; U' = single bond, S, O, NH, carbonyl, -R8O-, -R8S-, -R8NH-, -R8OR9-, -R8-NH-R9-, -R8-CO-R9- or -R9- (with R8 bound to T and R9 bound to V'); R8 = 1-6C alkylene; R9 = arylene or heteroarylene; V' = 1-6C alkylene; R4 = biaryl, arylheteroaryl, heteroarylaryl, 1-6C alkyl (optionally substituted by one heterocyclic group), cycloalkyl, aryl, 1-6C arylalkyl, cycloalkyl-1-6C alkyl or heterocyclic; and provided that R4 is 1-6C alkyl (optionally substituted by one heterocyclic group), cycloalkyl, aryl, 1-6C arylalkyl, cycloalkyl-1-6C alkyl or heterocyclic, when R3 is T-U'-V'-. An Independent claim is also included for the preparation of (I).
-
公开(公告)号:NZ516338A
公开(公告)日:2003-05-30
申请号:NZ51633800
申请日:2001-12-21
Applicant: SERVIER LAB
Inventor: DE NANTEUIL GUILLAUME , BENOIST ALAIN , PASTOUREAU PHILIPPE , SABATINI MASSIMO , HICKMAN JOHN , PIERRE ALAIN , TUCKER GORDON
IPC: C07D491/048 , A61K31/4433 , A61K31/444 , A61K31/541 , A61P9/10 , A61P19/02 , A61P29/00 , A61P35/00 , A61P43/00 , C07D405/14 , C07D417/14 , C07D491/04 , A61K31/443
Abstract: A 2-(4-pyridinyl)-benzofuran derivative or an isomer, N-oxide or salt thereof useful as a metalloprotease inhibitor has the formula (I) wherein: R1 is H, halo, alkyl or alkoxy; X is oxygen, sulphur or NR; R is H or alkyl; A is a group of formula (2); Ra is H, alkyl or alkoxy; Rb and Rc is independently H or alkyl and n is 0 to 2.
-
公开(公告)号:CZ20022992A3
公开(公告)日:2003-02-12
申请号:CZ20022992
申请日:2001-03-06
Applicant: SERVIER LAB
Inventor: CASARA PATRICK , PERRON-SIERRA FRANCOISE , ATASSI GHANEM , TUCKER GORDON , SAINT-DIZIER DOMINIQUE
IPC: C07D233/24 , A61K31/4164 , A61K31/4168 , A61K31/417 , A61K31/4184 , A61K31/426 , A61K31/4375 , A61K31/44 , A61K31/4402 , A61K31/505 , A61K31/55 , A61P9/00 , A61P19/10 , A61P27/02 , A61P29/00 , A61P33/14 , A61P35/00 , A61P43/00 , C07D213/36 , C07D213/74 , C07D223/04 , C07D223/12 , C07D233/48 , C07D233/54 , C07D235/10 , C07D235/14 , C07D235/30 , C07D239/14 , C07D277/18 , C07D277/20 , C07D277/42 , C07D401/12 , C07D403/12 , C07D471/04
Abstract: Compounds of formula (1):wherein:G represents an optionally substituted phenyl or optionally substituted heterocycle, G1 and G2 being N or C,T1 represents -CH2-CH2-, -CH=CH- or =CH-CH2-, and T2 is a bond, or T1 represents -CH2- or =CH- and T2 is -CH2-, =CH-,R5 represents -(CH2)m-COOR6,R6 and R6' represent hydrogen, alkyl, optionally substituted aryl or optionally substituted arylalkyl,A represents -CO-, -CH2-, =CH- or -CH= and W represents -CH-, =C- or -C=, or A represents -CO- or -CH2- and W represents N,X represents -CO-X1-, -CO-NR6-X1-, -NR6-CO-X1-, -O-X1-, -SO2-NR6-X1- or -S(O)n-X1-,Y represents -Y1-, -Y2-Y1- or -Y1-Y2-Y1-, Y1 being an alkylene, alkenylene or alkynylene, and Y2 being an arylene, heteroarylene, cycloalkylene or heterocycloalkylene,Z represents -Z1-, -Z10-NR6-, and -Z10-NR6-CO-, Z1 being a heteroaryl, heterocycloalkyl, heteroarylalkyl, heterocycloalkylalkyl, fused arylheteroaryl, fused arylheterocycloalkyl, fused heteroarylheterocycloalkyl, fused heterocycloalkylheteroaryl or fused heteroarylheteroaryl, each of which is optionally substituted, or a group,Z2-NR6 or Z2-NR6-CO, Z2 being a group Z1, alkyl or heteroalkyl, andZ10 represents Z1 or an alkyl,its enantiomers, diastereoisomers, and addition salts thereof with a pharmaceutically acceptable acid or base,and medicinal products containing the same which are useful as vitronectin receptor antagonists.
-
公开(公告)号:BR0108998A
公开(公告)日:2002-12-17
申请号:BR0108998
申请日:2001-03-06
Applicant: SERVIER LAB
Inventor: CASARA PATRICK , PERRON-SIERRA FRANCOISE , ATASSI GHANEM , TUCKER GORDON , SAINT-DIZIER DOMINIQUE
IPC: C07D233/24 , A61K31/4164 , A61K31/4168 , A61K31/417 , A61K31/4184 , A61K31/426 , A61K31/4375 , A61K31/44 , A61K31/4402 , A61K31/505 , A61K31/55 , A61P9/00 , A61P19/10 , A61P27/02 , A61P29/00 , A61P33/14 , A61P35/00 , A61P43/00 , C07D213/36 , C07D213/74 , C07D223/04 , C07D223/12 , C07D233/48 , C07D233/54 , C07D235/10 , C07D235/14 , C07D235/30 , C07D239/14 , C07D277/18 , C07D277/20 , C07D277/42 , C07D401/12 , C07D403/12 , C07D471/04
Abstract: Compounds of formula (1):wherein:G represents an optionally substituted phenyl or optionally substituted heterocycle, G1 and G2 being N or C,T1 represents -CH2-CH2-, -CH=CH- or =CH-CH2-, and T2 is a bond, or T1 represents -CH2- or =CH- and T2 is -CH2-, =CH-,R5 represents -(CH2)m-COOR6,R6 and R6' represent hydrogen, alkyl, optionally substituted aryl or optionally substituted arylalkyl,A represents -CO-, -CH2-, =CH- or -CH= and W represents -CH-, =C- or -C=, or A represents -CO- or -CH2- and W represents N,X represents -CO-X1-, -CO-NR6-X1-, -NR6-CO-X1-, -O-X1-, -SO2-NR6-X1- or -S(O)n-X1-,Y represents -Y1-, -Y2-Y1- or -Y1-Y2-Y1-, Y1 being an alkylene, alkenylene or alkynylene, and Y2 being an arylene, heteroarylene, cycloalkylene or heterocycloalkylene,Z represents -Z1-, -Z10-NR6-, and -Z10-NR6-CO-, Z1 being a heteroaryl, heterocycloalkyl, heteroarylalkyl, heterocycloalkylalkyl, fused arylheteroaryl, fused arylheterocycloalkyl, fused heteroarylheterocycloalkyl, fused heterocycloalkylheteroaryl or fused heteroarylheteroaryl, each of which is optionally substituted, or a group,Z2-NR6 or Z2-NR6-CO, Z2 being a group Z1, alkyl or heteroalkyl, andZ10 represents Z1 or an alkyl,its enantiomers, diastereoisomers, and addition salts thereof with a pharmaceutically acceptable acid or base,and medicinal products containing the same which are useful as vitronectin receptor antagonists.
-
-
-
-
-
-
-
-
-